Correlation Between Bristol Myers and GRAIL, LLC

Can any of the company-specific risk be diversified away by investing in both Bristol Myers and GRAIL, LLC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bristol Myers and GRAIL, LLC into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Bristol Myers Squibb and GRAIL, LLC, you can compare the effects of market volatilities on Bristol Myers and GRAIL, LLC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bristol Myers with a short position of GRAIL, LLC. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bristol Myers and GRAIL, LLC.

Diversification Opportunities for Bristol Myers and GRAIL, LLC

-0.11

Correlation Coefficient

Bristol Myers  GRAIL, LLC

Good diversification

The 3 months correlation between Bristol and GRAIL, is -0.11. Overlapping area represents the amount of risk that can be diversified away by holding Bristol Myers Squibb and GRAIL, LLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GRAIL, LLC and Bristol Myers is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bristol Myers Squibb are associated (or correlated) with GRAIL, LLC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GRAIL, LLC has no effect on the direction of Bristol Myers i.e., Bristol Myers and GRAIL, LLC go up and down completely randomly.

Pair Corralation between Bristol Myers and GRAIL, LLC

Considering the 90-day investment horizon Bristol Myers is expected to generate 76.16 times less return on investment than GRAIL, LLC. But when comparing it to its historical volatility, Bristol Myers Squibb is 6.0 times less risky than GRAIL, LLC. It trades about 0.01 of its potential returns per unit of risk. GRAIL, LLC is currently generating about 0.17 of returns per unit of risk over similar time horizon. If you would invest  1,873  in GRAIL, LLC on December 1, 2024 and sell it today you would earn a total of  1,983  from holding GRAIL, LLC or generate 105.87% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Bristol Myers Squibb  vs.  GRAIL, LLC

Bristol Myers Squibb

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Bristol Myers Squibb are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong primary indicators, Bristol Myers is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

GRAIL, LLC

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in GRAIL, LLC are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite quite fragile basic indicators, GRAIL, LLC disclosed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Bristol Myers and GRAIL, LLC

The main advantage of trading using opposite Bristol Myers and GRAIL, LLC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bristol Myers position performs unexpectedly, GRAIL, LLC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GRAIL, LLC will offset losses from the drop in GRAIL, LLC's long position.

The idea behind Bristol Myers Squibb and GRAIL, LLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.